Industrial research of new DNA technologies for medical diagnosis: next generation sequencing and miRNA (Q10109): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Change because item Q214251 was merged with Q4868) |
(Changed label, description and/or aliases in fr: translated_label) |
||
| label / fr | label / fr | ||
Recherche industrielle sur les nouvelles technologies de l’ADN pour le diagnostic médical: séquençage de la prochaine génération et miRNA | |||
Revision as of 09:06, 28 November 2021
Project Q10109 in Czech Republic
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Industrial research of new DNA technologies for medical diagnosis: next generation sequencing and miRNA |
Project Q10109 in Czech Republic |
Statements
10,847,356.92 Czech koruna
0 references
18,868,250.0 Czech koruna
0 references
57.49 percent
0 references
1 January 2016
0 references
28 September 2019
0 references
ELISABETH PHARMACON, spol. s r.o.
0 references
49°11'55.75"N, 16°38'29.22"E
0 references
61500
0 references
Projekt se zaměřuje na výzkum v nové oblasti DNA technologií s velkým potenciálem budoucího využití v klinické praxi pro zlepšení diagnostiky civilizačních chorob. Cílem projektu je výzkum klinicky významných miRNA molekul a jejich detekce a příprava dvou prototypů souprav pro sekvenování nové generace určených pro diagnostiku cystické fibrózy a rakoviny prsu a vaječníků. Výstupem projektu budou dva prototypy, na které bude možné navázat vývoj komerčních diagnostických souprav. a. (Czech)
0 references
The project focuses on research in the new field of DNA technologies with great potential for future use in clinical practice to improve the diagnosis of civilisation diseases. The aim of the project is to research clinically important miRNA molecules and their detection and preparation of two prototype kits for next generation sequencing for diagnosis of cystic fibrosis and breast and ovarian cancer. The output of the project will be two prototypes, on which the development of commercial diagnostic kits will be possible. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/15_018/0004701
0 references